Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
191 |
|
| Actual shortage: | 2 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 186 (97%) | |
Discontinuation Reports |
30 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (97%) | |
| Reversed: | 1 (3%) | |
Late reports |
9 (4%) |
|
Overdue reports |
1 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| 5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56909 |
| 5% DEXTROSE INJECTION, USP | 5G | LIQUID | Resolved | 2018-07-30 | 2018-10-10 | 56912 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-02-15 | 2019-03-01 | 76027 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-08-27 | 2019-10-10 | 92505 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-09-20 | 2019-10-10 | 94473 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-11-05 | 2019-11-12 | 97992 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-01-17 | 2020-02-11 | 103477 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-10 | 2020-03-21 | 108434 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-12 | 2020-04-08 | 108635 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-17 | 150508 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-02 | 150511 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-08-24 | 150514 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-09-02 | 165961 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-08-30 | 165965 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-10-26 | 171211 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-12-01 | 171215 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-03-15 | 2023-03-31 | 187084 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-04-12 | 2023-04-29 | 189362 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-07-06 | 2023-07-31 | 197756 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-10-11 | 2023-10-24 | 206816 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SELECTBAG ONE (AX275G) | 36.0G 220.0G 51.5G 29.8G 20.3G | SOLUTION | Discontinued | 2020-10-07 | 2020-12-18 | 125887 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |
| CIPROFLOXACIN INJECTION | 2MG | SOLUTION | Discontinued | 2020-07-21 | 2020-08-17 | 120710 |
| CLINIMIX | 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 10G 365MG 280MG 290MG 200MG 300MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-04-20 | 118601 |
| CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
| CLINIMIX | 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 16.6G 365MG 280MG 290MG | SOLUTION | Discontinued | 2020-06-22 | 2022-12-08 | 118612 |
| ACID CONCENTRATE 2171 | 112.53G 5.4G 3.21G 2.5G 8.39G 262.98G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7252 |
| ACID CONCENTRATE 2198 | 10.8G 1.61G 7.49G 10.1G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7255 |
| ACID CONCENTRATE D12292 | 10.8G 1.61G 6.24G 3.35G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7261 |
| 1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION SOLUTION | Discontinued | 2022-12-13 | 2023-01-01 | 178273 |